Detalles de la búsqueda
1.
Anti-SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report.
Kidney Int
; 100(5): 1136-1138, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34419552
2.
Impact of donor-specific antibody with low mean fluorescence intensity on allograft outcomes in kidney transplant.
Transpl Immunol
; 84: 102054, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38750972
3.
A 46-Year-Old Thai Woman with Secondary Acquired Pure Red Cell Aplasia Due to Treatment with Recombinant Erythropoietin While on Dialysis for End-Stage Renal Disease Who Recovered Following ABO-Incompatible Kidney Transplantation.
Am J Case Rep
; 23: e935451, 2022 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35842751
4.
Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients.
Sci Rep
; 12(1): 3587, 2022 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35246578
5.
Short-Term Immunogenicity Profiles and Predictors for Suboptimal Immune Responses in Patients with End-Stage Kidney Disease Immunized with Inactivated SARS-CoV-2 Vaccine.
Infect Dis Ther
; 11(1): 351-365, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34859359
6.
Durability of Humoral and Cellular Immunity after an Extended Primary Series with Heterologous Inactivated SARS-CoV-2 Prime-Boost and ChAdOx1 nCoV-19 in Dialysis Patients (ICON3).
Vaccines (Basel)
; 10(7)2022 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35891228
Resultados
1 -
6
de 6
1
Próxima >
>>